ライフサイエンスコーパス: cord blood-derived

1 more polyunsaturated fatty acids (PUFA) than cord blood-derived AFP.

2 y increased by tumor-derived, but not normal cord blood-derived, AFP, leading to increased glucose up

3 C9i also enhanced apoptosis in cord blood-derived CD19(+) B-lineage cells (but not myel

4 e, enucleated erythroid cells from umbilical cord blood derived CD34(+) haematopoietic progenitor cel

5 were generated by transplanting fresh human cord blood-derived CD34 stem cells into sub-lethally irr

6 Human hematopoietic cell lines and cord blood-derived CD34(+) and CD34(+), CD38(-) cell pop

7 ersulfone nanofiber-expanded human umbilical cord blood-derived CD34(+) cells (henceforth CD34(+) cel

8 HDR-mediated COL7A1 modification in healthy cord blood-derived CD34(+) cells and mesenchymal stem ce

9 ression of the NUP98-HOXA9 fusion protein in cord blood-derived CD34(+) cells confers a proliferative

10 od for generating genetically modified human cord blood-derived CD34(+) cells for transplantation, re

11 In vitro pDC generation from human cord blood-derived CD34(+) hematopoietic progenitors was

12 n immune system was generated from umbilical cord blood-derived CD34(+) hematopoietic stem cells in B

13 cooperates with MA4 to initiate leukemia in cord blood-derived CD34(+) hematopoietic stem/progenitor

14 EV treatment of human umbilical cord blood-derived CD34(+) HSPCs alters the expression o

15 Accordingly, the treatment of umbilical cord blood-derived CD34(+) HSPCs with stimulatory EVs-al

16 hairpin RNA knockdown of CLC/Gal-10 in human cord blood-derived CD34(+) progenitor cells impairs eosi

17 1A (LSD1) induces a rapid expansion of human cord blood-derived CD34+ cells and promotes in vitro pro

18 When human cord blood-derived CD34+ cells are induced to differenti

19 f ligands for both P- and E-selectins on all cord blood-derived CD34+ cells.

20 human promyelocytic HL-60 cells and healthy cord blood-derived CD34+ hematopoietic stem and progenit

21 Cord blood-derived CD4(+) T cells are largely naive and

22 Comparison with expanded cord blood-derived CD4(+)CD25(hi) tTreg and expanded Tef

23 mbined with ex vivo expanded human umbilical cord blood-derived CD8(+) T cells, that have been geneti

24 Umbilical cord blood-derived cells (UCBCs) are increasingly being

25 Cord blood-derived cells surrounding surfactant-immunore

26 ransplanted lineage-depleted human umbilical cord blood-derived cells with high aldehyde dehydrogenas

27 Human LAD2 cells and umbilical primary human cord blood-derived cultured mast cells were stimulated w

28 d TNF from LAD2 cells and of CCL2 from human cord blood-derived cultured MCs.

29 Cord blood-derived cultured suppressor cell function was

30 Here we studied cord-blood-derived cytokine-preactivated and expanded NK

31 DNA methylation of cord-blood derived DNA from 134 infants involved in a pr

32 Cord blood-derived ECFC therapy may offer new therapeuti

33 Intrajugular administration of human cord blood-derived ECFCs after established arrested alve

34 We examined the effects of human umbilical cord blood-derived ECFCs and their extracellular vesicle

35 studies indicate protective effects of human cord blood-derived ECFCs in experimental AKI and suggest

36 deficient mice in the presence or absence of cord blood-derived ECFCs.

37 Cs, the endothelial layer consisted of human cord blood-derived endothelial progenitor cells (hCB-EPC

38 lating factor in cultures of human umbilical cord blood-derived eosinophil (CDE) precursor cells.

39 Umbilical cord blood-derived EPCs (cbEPCs) were analyzed in parall

40 generated by peripheral blood- and umbilical cord blood-derived EPCs in a model of in vivo vasculogen

41 However, similar to adult- and cord blood-derived EPCs, HUVECs and HAECs derived from v

42 racterized the dynamic adhesion of umbilical-cord-blood-derived EPCs (CB-EPCs) to surfaces coated wit

43 ated results are obtained in human umbilical cord blood-derived erythroid progenitor-2 cells, in whic

44 Umbilical cord blood-derived haematopoietic stem cells (HSCs) are

45 the stem cell activity of cultured umbilical cord blood derived hematopoietic cells.

46 splants by intrahepatic inoculation of human cord blood-derived hematopoietic progenitor cells (CD34(

47 criptomes of unexpanded and ex vivo cultured cord blood-derived hematopoietic stem and progenitor cel

48 ator of adhesive properties in primary human cord blood-derived hematopoietic stem and progenitor cel

49 udy, we genetically modified human umbilical cord blood-derived hematopoietic stem cells (HSCs) to ex

50 lts in a marked expansion of human umbilical cord blood-derived HSPCs following cytokine stimulation.

51 We found that umbilical cord blood-derived HSPCs showed the greatest transplanta

52 rived pDCs (HSPC-pDCs) starting from 100,000 cord blood-derived HSPCs.

53 g, and functionally regulating healthy human cord blood-derived HSPCs.

54 nt CD34(+) erythroleukemic cell line, and in cord blood-derived human CD34(+) cells.

55 Rag2(-)/(-)gammac(-)/(-) mice humanized with cord blood-derived human hematopoietic stem cells produc

56 erism were observed after transplantation of cord blood-derived human HSCs into nonirradiated adult a

57 ulation of the human LAD2 mast-cell line and cord blood-derived human mast cells (hMCs).

58 adenine nucleotide-specific P2Y receptors on cord blood-derived human mast cells (hMCs).

59 Cord blood-derived human mast cells were treated with IL

60 Fc epsilon RI expression in these umbilical cord blood-derived human mast cells, as well as in mouse

61 Cord blood-derived human MC (hMC) express functional rec

62 Cultured cord blood-derived human MCs (hMCs) express mRNA transcr

63 sion and CysLT(1)-dependent proliferation of cord blood-derived human MCs (hMCs).

64 Moreover, preparations of human umbilical cord blood-derived immature mast cells not only expresse

65 TB(4) was a potent chemoattractant for human cord blood-derived immature, but not mature, mast cells.

66 s prolong VEGFR-2 and Akt phosphorylation in cord blood-derived late outgrowth endothelial progenitor

67 es revealed that iDMs were highly similar to cord blood-derived macrophages and BMDMs, and resembled

68 Similarly, human cord blood-derived macrophages express IL-27 genes and s

69 ary human stem cell-derived macrophages from cord blood-derived macrophages or bone marrow-derived ma

70 leukotriene C(4) synthase (LTC(4)S) by human cord blood--derived mast cells (hMCs), augments their hi

71 We now demonstrate that human cord blood-derived mast cell progenitors are susceptible

72 protease tryptase in normal human umbilical cord blood-derived mast cells (hCBMCs).

73 howed that the native MCEMP1 is expressed in cord blood-derived mast cells and HMC-1 and THP-1 cell l

74 Cord blood-derived mast cells and human mast cell line L

75 Human cord blood-derived mast cells and the HMC-1 mast cell li

76 rkC, whereas preparations of human umbilical cord blood-derived mast cells expressed mRNAs for trkA a

77 e of the type I interferon receptor on human cord blood-derived mast cells reduced the RSV-mediated i

78 uman leukemic mast cells and human umbilical cord blood-derived mast cells to release newly synthesiz

79 Human cord blood-derived mast cells undergo apoptosis upon exp

80 Human cord blood-derived mast cells were treated for 2 weeks w

81 ine bone marrow-derived mast cells and human cord blood-derived mast cells.

82 le development and function were examined in cord blood-derived mast cells.

83 mRNA and protein were present only in human cord blood-derived mast cells.

84 c mast cell (HMC-1) line and human umbilical cord blood-derived mast cells.

85 ergic donors' basophils and sensitized human cord blood-derived mast cells.

86 s IgE-desensitized rat MC and human lung and cord blood-derived MC (CBMC) after priming with fibrobla

87 S1P accelerated the development of cord blood-derived MCs (CB-MCs) and strikingly increased

88 The LAD2 MC line or primary human cord blood-derived MCs (CBMCs) were infected with HRV or

89 We now report that human cord-blood-derived MCs (hMCs) express the CysLT1 recepto

90 Among systemic therapies, current data on cord-blood-derived mesenchymal stem cells, CM310 (anti I

91 e marrow MKs, platelets, and differentiating cord blood-derived MK cultures, and identified MK miR-12

92 antitative and functional characteristics of cord blood-derived mononuclear cells (CB-MNCs) and CD31-

93 nduction were similar to levels achieved for cord blood-derived MPP and up to 20-fold higher than tho

94 ing with donor DNA repair templates in human cord blood-derived, naive T cells to generate PTPN22 ris

95 We conducted a phase 1/2 trial of cord blood-derived natural killer (NK) cells expressing

96 imeric antigen receptor (CAR) engineering of cord blood-derived natural killer (NK) cells.

97 adoptive transfer of ex vivo expanded human cord blood-derived NK cells into humanized mice reconsti

98 w Notch influences terminal differentiation, cord blood-derived NK cells or sorted peripheral blood N

99 Overexpression of activated Notch on cord blood-derived NK cells resulted in a 2-fold increas

100 lthy donors were cultured in the presence of cord blood-derived normal AFP (nAFP) or HCC tumor-derive

101 Umbilical cord blood-derived products marketed as stem cell treatm

102 ctions following administration of umbilical cord blood-derived products marketed as stem cell treatm

103 successfully differentiated human umbilical cord blood-derived progenitor cells into CARiK cells.

104 MCs developed from cord blood-derived progenitors cultured with stem cell f

105 rily focused on the more extensively studied cord blood-derived stem cell.

106 CD8+,CD57+ T cells were cocultured with cord blood-derived stem cells, and percentage inhibition

107 the growth of normal cells, including human cord blood-derived stem cells.

108 hairpin RNA (shRNA) library transduced into cord blood-derived stem/progenitor cells.

109 Cord blood-derived surfactant-positive epithelial cells

110 e expression of these receptors on adult and cord blood-derived term and preterm neonatal B cells.

111 entified potential mechanisms by which human cord blood derived unrestricted somatic stem cells (USSC